Bristol-Myers Squibb Agrees to Clean Air Ac...(ne-depletion regulations for the Evansvi...),Health

Date:7/8/2008

ne-depletion regulations for the Evansville facility, Bristol-Myers Squibb voluntarily conducted an audit of 25 of its other facilities and reported all potential violations that were discovered. The audit uncovered potential violations at the 13 facilities located in six states -- Connecticut, Indiana, Massachusetts, Michigan, New Jersey, New York -- and in Puerto Rico.

"Bristol-Myers Squibb has acted responsibly, not only to discover, document and correct past violations, but to eliminate the use of potentially damaging refrigerants in its operations," said Granta Nakayama, assistant administrator for EPA's Office of Enforcement and Compliance Assurance. "These actions will help protect the ozone layer, ensuring a safer environment for our future generations."

"Bristol-Myers Squibb took action and reported Clean Air Act violations at multiple facilities and is now committed to removing thousands of pounds of harmful ozone-depleting refrigerants from its operations," said Ronald J. Tenpas, assistant attorney general for the Justice Department's Environmental and Natural Resources Division. "We are pleased that, after violating our ozone protection requirements, Bristol-Myers Squibb is now committed to a settlement that will be good for the environment and good business practice."

The proposed consent decree, lodged in the U.S. District Court for the Southern District of Indiana, is subject to a 30-day public comment period and approval by the federal court. Bristol-Myers Squibb is required to pay the penalty within 30 days of the court's approval of the settlement. A copy of the consent decree lodged today is available at the Department of Justice Web site at http://www.usdoj.gov/enrd/open.html.

More about EPA and ozone depletion is at http://www.epa.gov/compliance/resources/d
'/>"/>

SOURCE U.S. Environmental Protection Agency Region 5 Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Bristol-Myers Squibb Announces Dividend
2. Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing
3. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
4. Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
5. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
6. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
7. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
8. Bristol-Myers Squibb Names Alan J. Lacy to Board of Directors
9. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
10. Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
11. Bristol-Myers Squibb to Present at Healthcare Conferences